Evidence map›Paper›PMID 40403021›Full record

ArticlePloS one2025

β-glucan induced trained immunity enhances antibody levels in a vaccination model in mice.

Jainu Ajit, Qing Chen, Trevor Ung, Matthew Rosenberger, Jeremiah Kim, Ani Solanki, Jingjing Shen, Aaron P Esser Kahn

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Myeloid cell reprogramming drives enhanced defense againstbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. High-throughput screen identifies non inflammatory small molecule inducers of trained immunity.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jainu AjitPritzker School of Molecular Engineering, University of Chicago, Chicago, Illinois, United States of America.
Qing ChenPritzker School of Molecular Engineering, University of Chicago, Chicago, Illinois, United States of America.
Trevor UngPritzker School of Molecular Engineering, University of Chicago, Chicago, Illinois, United States of America.
Matthew RosenbergerPritzker School of Molecular Engineering, University of Chicago, Chicago, Illinois, United States of America.
Jeremiah KimPritzker School of Molecular Engineering, University of Chicago, Chicago, Illinois, United States of America.
Ani SolankiPritzker School of Molecular Engineering, University of Chicago, Chicago, Illinois, United States of America.
Jingjing ShenPritzker School of Molecular Engineering, University of Chicago, Chicago, Illinois, United States of America.
Aaron P Esser KahnPritzker School of Molecular Engineering, University of Chicago, Chicago, Illinois, United States of America.ORCID https://orcid.org/0000-0003-1273-0951

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trained immunity improves disease resistance by strengthening our first line of defense, the innate immune system. Innate immune cells, predominantly macrophages, are epigenetically and metabolically rewired by β-glucan, a fungal cell wall component, to induce trained immunity. These trained macrophages exhibit increased co-stimulatory marker expression and altered cytokine production. Signaling changes from antigen-presenting cells, including macrophages, polarize T-cell responses. Recent work has shown that trained immunity can generally enhance protection against infection, and some work has shown increased protection with specific vaccines. It has been hypothesized that the trained cells themselves potentially modulate adaptive immunity in the context of vaccines. However, the mechanistic link between trained immunity and subsequent vaccinations to enhance antibody levels has not yet been identified. We report that trained immunity induced by a single dose of β-glucan increased antigen presentation in bone-marrow-derived macrophages (BMDMs) and CD4+ T cell proliferation in-vitro. Mice trained with a single dose of β-glucan a week before vaccination elicited higher antigen-specific antibody levels than untrained mice. Further experiments validate that macrophages mediate this increase. This effect persisted even after vaccinations with 100 times less antigen in trained mice. We report β-glucan training as a novel prophylactic method to enhance the effect of subsequent vaccines.

Indexed as

beta-GlucansVaccinationAnimalsAntigen PresentationCD4-Positive T-LymphocytesCell ProliferationFemaleImmunity, InnateMacrophagesMiceMice, Inbred C57BLTrained Immunitybeta-Glucans

Identifiers

PMID40403021
PMCPMC12097602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.